Extracellular pyrophosphate in the kidney: How does it get there and what does it do?

Nephron - Physiology

Volumn 120, Issue 4, 2012, Pages

  Moochhala, Shabbir H ^a  

^a ROYAL FREE HOSPITAL   (United Kingdom)

Author keywords

ANK; ANKH; Calcification; Efflux; Membrane transport; Pyrophosphate

Indexed keywords

5' NUCLEOTIDASE; ALKALINE PHOSPHATASE; AQUAPORIN 2; ARGIPRESSIN; CALCIUM PYROPHOSPHATE; INORGANIC PYROPHOSPHATASE; PYROPHOSPHATE; TRANSCRIPTION FACTOR PIT 1;

AUTOSOMAL DOMINANT INHERITANCE; BLOOD VESSEL CALCIFICATION; CELL COMPARTMENTALIZATION; EFFUSION; EXTRACELLULAR SPACE; GAIN OF FUNCTION MUTATION; GENETIC CONSERVATION; HUMAN; HYDROLYSIS; HYPOTHESIS; IMMUNOPRECIPITATION; KIDNEY CALCIFICATION; KIDNEY FAILURE; MEMBRANE TRANSPORT; NEGATIVE FEEDBACK; NONHUMAN; PATHOPHYSIOLOGY; PHENOTYPE; PRIORITY JOURNAL; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM;

ANIMALS; AQUAPORIN 2; CALCINOSIS; CILIA; DIPHOSPHATES; HUMANS; KIDNEY; MEMBRANE TRANSPORT PROTEINS; MICE; MUTATION; NEPHROCALCINOSIS; ORGAN SPECIFICITY; PHOSPHATE TRANSPORT PROTEINS; RENAL INSUFFICIENCY;

EID: 84867454537     PISSN: None     EISSN: 16602137     Source Type: Journal    
DOI: 10.1159/000341597     Document Type: Review

References (24)

1. Fleisch H, Bisaz S: Isolation from urine of pyrophosphate, a calcification inhibitor. Am J Physiol 1962; 203: 671-675.
2. Sidhu H, Gupta R, Thind SK, Nath R: Inhibition of calcium oxalate monohydrate (COM) crystal growth by pyrophosphate, citrate and rat urine. Urol Res 1986; 14: 299-303.
3. Ho AM, Johnson MD, Kingsley DM: Role of the mouse ank gene in control of tissue calcification and arthritis. Science 2000; 289: 265-270.
4. Lee DH, Kim SY, Hong JI: A fluorescent pyrophosphate sensor with high selectivity over ATP in water. Angew Chem Int Ed Engl 2004; 43: 4777-4780.
5. Carr G, Sayer JA, Simmons NL: Expression and localisation of the pyrophosphate transporter, ANK, in murine kidney cells. Cell Physiol Biochem 2007; 20: 507-516.
6. Morava E, Kuhnisch J, Drijvers JM, Robben JH, Cremers C, van Setten P, Branten A, Stumpp S, de Jong A, Voesenek K, Vermeer S, Heister A, Claahsen-van der Grinten HL, O'Neill CW, Willemsen MA, Lefeber D, Deen PM, Kornak U, Kremer H, Wevers RA: Autosomal recessive mental retardation, deafness, ankylosis, and mild hypophosphatemia associated with a novel ANKH mutation in a consanguineous family. J Clin Endocrinol Metab 2011; 96:E189-E198.
7. Collins MT, Boehm M: It ANKH necessarily so. J Clin Endocrinol Metab 2011; 96: 72-74.
8. O'Neill WC, Sigrist MK, McIntyre CW: Plasma pyrophosphate and vascular calcification in chronic kidney disease. Nephrol Dial Transplant 2010; 25: 187-191.
9. Rutsch F, Vaingankar S, Johnson K, Goldfine I, Maddux B, Schauerte P, Kalhoff H, Sano K, Boisvert WA, Superti-Furga A, Terkeltaub R: PC-1 nucleoside triphosphate pyrophosphohydrolase deficiency in idiopathic infantile arterial calcification. Am J Pathol 2001; 158: 543-554.
10. O'Neill WC, Lomashvili KA, Malluche HH, Faugere MC, Riser BL: Treatment with pyrophosphate inhibits uremic vascular calcification. Kidney Int 2011; 79: 512-517.
11. Nitta K, Akiba T, Suzuki K, Uchida K, Watanabe R, Majima K, Aoki T, Nihei H: Effects of cyclic intermittent etidronate therapy on coronary artery calcification in patients receiving long-term hemodialysis. Am J Kidney Dis 2004; 44: 680-688.
12. Gurley KA, Reimer RJ, Kingsley DM: Biochemical and genetic analysis of ANK in arthritis and bone disease. Am J Hum Genet 2006; 79: 1017-1029.
13. Wang J, Tsui HW, Beier F, Tsui FWL: The CPPDD-associated ANKH M48T mutation interrupts the interaction of ANKH with the sodium/phosphate cotransporter PiT-1. J Rheumatol 2009; 36: 1265-1272.
14. Carr G, Moochhala SH, Eley L, Vandewalle A, Simmons NL, Sayer JA: The pyrophosphate transporter ANKH is expressed in kidney and bone cells and colocalises to the primary cilium/basal body complex. Cell Physiol Biochem 2009; 24: 595-604.
15. St Hilaire C, Ziegler SG, Markello TC, Brusco A, Groden C, Gill F, Carlson-Donohoe H, Lederman RJ, Chen MY, Yang D, Siegenthaler MP, Arduino C, Mancini C, Freudenthal B, Stanescu HC, Zdebik AA, Chaganti RK, Nussbaum RL, Kleta R, Gahl WA, Boehm M: NT5E mutations and arterial calcifications. N Engl J Med 2011; 364: 432-442.
16. Vekaria RM, Shirley DG, Sevigny J, Unwin RJ: Immunolocalization of ectonucleotidases along the rat nephron. Am J Physiol Renal Physiol 2006; 290:F550-F560.
17. Pendleton A, Johnson MD, Hughes A, Gurley KA, Ho AM, Doherty M, Dixey J, Gillet P, Loeuille D, McGrath R, Reginato A, Shiang R, Wright G, Netter P, Williams C, Kingsley DM: Mutations in ANKH cause chondrocalcinosis. Am J Hum Genet 2002; 71: 933-940.
18. Zhang Y, Brown MA: Genetic studies of chondrocalcinosis. Curr Opin Rheumatol 2005; 17: 330-335.
19. McKee S, Pendleton A, Dixey J, Doherty M, Hughes A: Autosomal dominant early childhood seizures associated with chondrocalcinosis and a mutation in the ANKH gene. Epilepsia 2004; 45: 1258-1260.
20. Reichenberger E, Tiziani V, Watanabe S, Park L, Ueki Y, Santanna C, Baur ST, Shiang R, Grange DK, Beighton P, Gardner J, Hamersma H, Sellars S, Ramesar R, Lidral AC, Sommer A, Raposo do Amaral CM, Gorlin RJ, Mulliken JB, Olsen BR: Autosomal dominant craniometaphyseal dysplasia is caused by mutations in the transmembrane protein ANK. Am J Hum Genet 2001; 68: 1321-1326.
21. Nurnberg P, Thiele H, Chandler D, Hohne W, Cunningham ML, Ritter H, Leschik G, Uhlmann K, Mischung C, Harrop K, Goldblatt J, Borochowitz ZU, Kotzot D, Westermann F, Mundlos S, Braun HS, Laing N, Tinschert S: Heterozygous mutations in ANKH, the human ortholog of the mouse progressive ankylosis gene, result in craniometaphyseal dysplasia. Nat Genet 2001; 28: 37-41.
22. Zajac A, Baek SH, Salhab I, Radecki MA, Kim S, Hakonarson H, Nah HD: Novel ANKH mutation in a patient with sporadic craniometaphyseal dysplasia. Am J Med Genet A 2010; 152A:770-776.
23. Gurley KA, Chen H, Guenther C, Nguyen ET, Rountree RB, Schoor M, Kingsley DM: Mineral formation in joints caused by complete or joint-specific loss of ANK function. J Bone Miner Res 2006; 21: 1238-1247.
24. Chen IP, Wang CJ, Strecker S, Koczon-Jaremko B, Boskey A, Reichenberger EJ: Introduction of a Phe377del mutation in ANK creates a mouse model for craniometaphyseal dysplasia. J Bone Miner Res 2009; 24: 1206-1215.